3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
2
Recruiting
2
Completed
2
Unknown
1
Not yet recruiting
1
No longer available
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
471
Neoplasms
328
Colorectal Neoplasms
235
Carcinoma, Non-Small-Cell Lung
234
Lung Neoplasms
200
Prostatic Neoplasms
179
Carcinoma, Hepatocellular
174
Stomach Neoplasms
138
Pancreatic Neoplasms
126
Leukemia, Myeloid, Acute
114
Uterine Cervical Neoplasms
110
Rectal Neoplasms
105
Multiple Myeloma
94
Recurrence
89
Squamous Cell Carcinoma of Head and Neck
84
Head and Neck Neoplasms
79
Neoplasm Metastasis
76
Ovarian Neoplasms
75
Brain Neoplasms
71
Colonic Neoplasms
68
Glioblastoma
67
Esophageal Neoplasms
66
Triple Negative Breast Neoplasms
65
Endometrial Neoplasms
58
Precursor Cell Lymphoblastic Leukemia-Lymphoma
56
Small Cell Lung Carcinoma
54
Disease
54
Motor Activity
53
Hematologic Neoplasms
53
Glioma
48
Interventions
Quality of Life
1
Electrocardiography
1
Clinical Laboratory Techniques
1
Bone Marrow Examination
1
Azacitidine
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
OTHER
×
Bone Marrow Diseases
×
Clear all
NCT07387354
2026-03-16
MDS
Thomas Jefferson University
Phase 1/2
Not yet recruiting
25 enrolled